Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Induction of marrow hypoxia by radioprotective agents

Technical Report ·
OSTI ID:7018562
Many compounds that possess sulfhydryl groups have been shown to protect bone marrow from radiation injury. The most effective thiol radioprotective agent is ethiofos (S-2-(3-aminopropylamino)ethylphosphorothoic acid or WR-2721). The ability of thiol and non-thiol radioprotectors to induce hypoxia was determined using binding of ({sup 3}H)misonidazole by bone marrow cells as a measure of hypoxia. When administered at maximally radioprotective doses, four drugs (WR-2721, cysteamine, 5-hydroxytryptamine, and 16,16-dimethyl prostaglandin E2) significantly increased the amount of ({sup 3}H)misonidazole bound by marrow cells, while no significant increase in binding was observed with three other agents (endotoxin, AET, superoxide dimutase). Doses of WR-2721 previously shown to provide suboptimal radioprotection did not significantly increase {sup 3}H-misonidazole binding. These results suggest that the physiological effects of some radioprotectors, that is, their ability to induce marrow hypoxia, may contribute to their efficacy in vivo.
Research Organization:
Armed Forces Radiobiology Research Inst., Bethesda, MD (USA)
OSTI ID:
7018562
Report Number(s):
AD-A-214330/3/XAB; AFRRI-SR--89-26
Country of Publication:
United States
Language:
English

Similar Records

Induction of marrow hypoxia by radioprotective agents
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Radiat. Res.; (United States) · OSTI ID:5716375

Reduced bone marrow pO2 following treatment with radioprotective drugs
Journal Article · Fri Jun 01 00:00:00 EDT 1990 · Radiation Research; (USA) · OSTI ID:6703901

Sodium hydrogen-S-(3-amino-3-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection. [/sup 60/Co]
Journal Article · Sun Feb 28 23:00:00 EST 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:7065926